IGPH
vs
ABT
IGPH
ABT
Over the past 12 months, IGPH has underperformed ABT, delivering a return of 0% compared to the ABT's 15% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
IGPH
ABT
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
IGEA Pharma NV
SIX:IGPH
|
0.0005
CHF
|
|||||
|
Abbott Laboratories
NYSE:ABT
|
109.23
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
IGPH, ABT
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
IGEA Pharma NV
Revenue
|
|||||||||||
|
Abbott Laboratories
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
IGPH, ABT
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
IGEA Pharma NV
SIX:IGPH
|
|||||||||
|
Abbott Laboratories
NYSE:ABT
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
IGPH, ABT
Performance Gap
IGPH, ABT
Performance By Year
IGPH, ABT
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.